Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated tetrodotoxin-sensitive (TTX-S) sodium channels are a critical subset of the voltage-gated sodium channel (Nav) family, defined by their high affinity for the neurotoxin tetrodotoxin. This group includes the isoforms Nav1.1, Nav1.2, Nav1.3, Nav1.4, Nav1.6, and Nav1.7, which are predominantly expressed in the central and peripheral nervous systems as well as skeletal muscle [1, 2]. These channels are responsible for the rapid influx of sodium ions that initiates the depolarization phase of the action potential, making them essential for electrical signaling in excitable tissues [1]. Dysregulation or genetic mutations in these channels are associated with a variety of channelopathies, including Dravet syndrome (Nav1.1), periodic paralysis (Nav1.4), and congenital insensitivity to pain or erythromelalgia (Nav1.7) [1, 5]. Pharmacologically, TTX-S channels are the primary targets for a wide range of clinical drugs, including local anesthetics, anti-epileptics, and anti-arrhythmics [3, 4]. While tetrodotoxin itself is a potent and potentially lethal toxin that can cause respiratory arrest by blocking these channels, it is also being explored as a therapeutic agent for managing severe chronic and cancer-related pain at sub-lethal concentrations [2, 3].
Drugs targeting these channels typically act by binding to the pore-forming alpha-subunit to block the influx of sodium ions. Specifically, tetrodotoxin and saxitoxin bind to neurotoxin receptor site 1 in the outer vestibule of the channel pore, physically occluding the permeation pathway and preventing ion flow. Other therapeutic agents, such as local anesthetics and anticonvulsants, bind to distinct sites (e.g., the local anesthetic site in the inner pore) to stabilize the channel in a non-conducting inactivated state, thereby reducing neuronal firing and preventing the propagation of pathological electrical signals like those found in pain or seizures.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated tetrodotoxin-sensitive sodium channel (TTX-S Nav channel) (TTX-S Nav channel).